Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11. by Mlynarski, W, Tarasov, A, Gach, A, Girard, C, Pietrzak, I, Zubcevic, L, Kusmierek, J, Klupa, T, Malecki, M, Ashcroft, F

Switching to sulphonylureas in children with iDEND syndrome caused by KCNJ11 mutations results in improved cerebellar perfusion. by Fendler, W, Pietrzak, I, Brereton, M, Lahmann, C, Gadzicki, M, Bienkiewicz, M, Drozdz, I, Borowiec, M, Malecki, M, Ashcroft, F, Mlynarski, WM